| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 10/05/2006 | US20060223984 Gamma-conopeptides |
| 10/05/2006 | US20060223881 Use of gamma- tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease |
| 10/05/2006 | US20060223865 Therapeutic combination |
| 10/05/2006 | US20060223853 e.g. 1-[2-hydroxy-3-(quinolin-5-yloxy)-propyl]-piperidine-4-carboxylic acid [4-phenyl-1-(3-phenyl-propyl)-butyl]-amide; multidrug resistance protein or P-glycoprotein modulator; with other therapeutic agent: anticarcinogenic, antibacterial, antiviral, antifungal agents |
| 10/05/2006 | US20060223836 New phenylalanine derivatives |
| 10/05/2006 | US20060223819 Quinoline Derivatives as NK-3 Antagonists |
| 10/05/2006 | US20060223818 N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-4-piperazin-1-ylmethyl-benzamide methanesulfonate; antiproliferative agent |
| 10/05/2006 | US20060223811 Triglycerine depressant composition |
| 10/05/2006 | US20060223800 Pyrazolopyridines and pyrazolopyridazines adn antidiabetics |
| 10/05/2006 | US20060223784 Method and compositions for temporarily incapacitating subjects |
| 10/05/2006 | US20060223779 Method of screening for inhibitors of human Fatty Acid-CoA Ligase 4 |
| 10/05/2006 | US20060223767 Vector for gene therapy and method of quantifying target protein in mammal or cultured cells with the administration of the vector for gene therapy |
| 10/05/2006 | US20060223763 C-glycoside compounds for stimulating the synthesis of glycosaminoglycans |
| 10/05/2006 | US20060223757 Applications in gene therapy, transgenic organisms, functional genomics, and other areas of cell and molecular biology. |
| 10/05/2006 | US20060223754 Human TSLP polynucleotides |
| 10/05/2006 | US20060223746 Injecting an alpha v beta 3 and/or alpha v beta 5 inhibitor, sufficient to inhibit or reduce angiogenesis or neovascularization in the treated eye, into the sclera layer of the eye; (2S)-2-benzyloxycarboxamido-3-(2-guanidinomethyl-1,4-benzodioxan-6-yl)propionic acid |
| 10/05/2006 | US20060223158 Regulation of neuronal function through metabotropic glutamate receptor signaling pathways |
| 10/05/2006 | US20060223121 Contacting biological sample of urine, cerebrospinal fluid or serum with a peptide and complexing with a monoclonal antibody ligand; detecting an immunogenic peptide having calgranulin B protein activity; Alzheimer's and Parkinson's disease, amyotrophic lateral sclerosis; rheumatoid arthritis |
| 10/05/2006 | US20060222628 Gallium complexes of 3-hydroxy-4-pyrones to treat infection by intracellular prokaryotes and DNA viruses |
| 10/05/2006 | CA2603125A1 Thienopyridine derivative, quinoline derivatives,and quinazoline derivatives, having c-met autophosphorylation inhibiting activity |
| 10/05/2006 | CA2602716A1 Therapeutic agent for non-alcoholic fatty liver disease, and screening method for drug candidate compound for treatment or prevention of non-alcoholic fatty liver disease |
| 10/05/2006 | CA2602351A1 Urea derivative, medicinal composition containing the same, and medicinal use of these |
| 10/04/2006 | EP1707571A1 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 10/04/2006 | EP1707567A1 Novel fused-ring compound |
| 10/04/2006 | EP1707566A1 Deazapurines and uses thereof |
| 10/04/2006 | EP1707563A2 Methods and compositions utilizing quinazolinones |
| 10/04/2006 | EP1707225A2 Methods and compositions for treating intervertebral disc degeneration |
| 10/04/2006 | EP1707214A1 Antagonists of HMG1 for treating inflammatory conditions and the use of HMG1 for effecting weightloss or treating obesity |
| 10/04/2006 | EP1707211A1 Ceramidase inhibitor |
| 10/04/2006 | EP1707205A2 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
| 10/04/2006 | EP1707193A2 Pharmaceutical composition for the prophylaxis and/or treatment of viral diseases |
| 10/04/2006 | EP1706105A1 Method of treating type iii hypersensitive reaction-related diseases and conditions by using conjugated linoleic acid |
| 10/04/2006 | EP1560589B1 Novel complexes of fatty acid esters of polyhydroxyalkanes and niacinamide |
| 10/04/2006 | EP1534658A4 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 10/04/2006 | EP1513840B1 Compounds and compositions for the treatment of diabetes and diabetes-related disorders |
| 10/04/2006 | EP1507527A4 Methods for enhancing motor performance and/or endurance |
| 10/04/2006 | EP1492786B1 Pyridinoylpiperidines as 5-ht1f agonists |
| 10/04/2006 | EP1487831B1 Difurylglycolic acid tropenol esters used as anticholinesterase drugs |
| 10/04/2006 | EP1482936B1 Ophthalmic composition comprising ascomycin |
| 10/04/2006 | EP1409481B1 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 10/04/2006 | EP1385840B1 Sulfonamides |
| 10/04/2006 | EP1377290B1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 10/04/2006 | EP1372653B1 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 10/04/2006 | EP1368019B1 Esmolol formulation |
| 10/04/2006 | EP1354602B1 Medicinal compositions containing diuretic and insulin resistance-improving agent |
| 10/04/2006 | EP1322621B1 New benzimidazolone derivatives displaying affinity at the serotonin and dopamine receptors |
| 10/04/2006 | EP1255827B1 Oligonucleotides and their use for modulating the expression of tyrosinase involved in the synthesis of melanic pigments |
| 10/04/2006 | EP1253945B1 Ace inhibitor-vasopressin antagonist combinations |
| 10/04/2006 | EP1206942B1 Water channel opener compositions and medicinal compositions for ophthalmic use |
| 10/04/2006 | EP1202746B1 Nsaid and egfr kinase inhibitor containing composition for the treatment or inhibition of colonic polyps and colorectal cancer |
| 10/04/2006 | EP1109918B1 Mitogen- and stress-activated protein kinases that contain two kinase domains and uses thereof |
| 10/04/2006 | EP1097382B1 Imidazoline receptor binding compounds |
| 10/04/2006 | EP1003861B1 Mammalian cell membrane proteins; related reagents |
| 10/04/2006 | EP0986644B1 Production of erythropoietin by endogenous gene activation with viral promoters |
| 10/04/2006 | EP0977873B1 Method for cleavage of fusion proteins |
| 10/04/2006 | EP0906091B1 Amidinohydrazones as protease inhibitors |
| 10/04/2006 | EP0841925B1 Endothelin receptor antagonists |
| 10/04/2006 | CN1842346A Regulation of the cytotoxic lymphocyte response by macrophage migration inhibitory factor |
| 10/04/2006 | CN1842341A Active fraction having anti-cancer and anti-metastic activity isolated from leaves and stems of ginseng |
| 10/04/2006 | CN1842333A Sustained release tablet for oral use |
| 10/04/2006 | CN1840529A Process for preparing an anticholinergic |
| 10/04/2006 | CN1840194A Injection liquid of human autogenous collagen living cell and preparation method thereof |
| 10/04/2006 | CN1840183A Use of sphingomyelinase for increasing the levels of skin and mucosal ceramides |
| 10/04/2006 | CN1840181A Therapeutic use of selective PDE10 inhibitors |
| 10/04/2006 | CN1840161A Chinese medicine for treating hernia and hydrocele |
| 10/04/2006 | CN1840154A Ointment for treating nervous damage and preparation method thereof |
| 10/04/2006 | CN1840102A Preparation containing lyophilized powder of deer fetus, its preparation method and use |
| 10/04/2006 | CN1840099A Anti-fatigue health-caring capsule |
| 10/04/2006 | CN1840098A Preparation method of yin-nourishing fatigue-eliminating wine with micron oligosaccharide, American ginseng, lily, cactus, official dendrobium stem and royal jelly |
| 10/04/2006 | CN1840097A Preparation method of yin-nourishing fatigue-eliminating simmer-free oral liquor with micron oligosaccharide, American ginseng, lily, cactus, official dendrobium stem and royal jelly |
| 10/04/2006 | CN1840095A Preparation method of yin-nourishing fatigue-eliminating tablet with micron oligosaccharide, American ginseng, lily, cactus, official dendrobium stem and royal jelly |
| 10/04/2006 | CN1840094A Preparation method of yin-nourishing fatigue-eliminating granule and capsule with micron oligosaccharide, American ginseng, lily, cactus, official dendrobium stem and royal jelly |
| 10/04/2006 | CN1840087A King solomonseal- and fleece-flower root-containing Chinese medicinal formulation for treating chronic fatigue syndrome and its preparation method |
| 10/04/2006 | CN1840001A Method for preparing mixture with pubescent angelica root and loranthus |
| 10/04/2006 | CN1839915A Preparation method of kidney-tonifying fatigue-eliminating boil-free oral liquid containing micropilose antler, safflower seeds etc. |
| 10/04/2006 | CN1839913A Preparation method of kidney-tonifying fatigue-eliminating tablet containing micropilose antler, safflower seeds etc. |
| 10/04/2006 | CN1839911A Preparation method of kidney-tonifying fatigue-eliminating liquor containing micropilose antler, safflower seeds etc. |
| 10/04/2006 | CN1839833A Pharmaceutical compositions based on anticholinergically effective compounds and beta-mimetics |
| 10/04/2006 | CN1839823A Compositions useful for the treatment of pathologies responding to the activation of ppar-gamma receptor |
| 10/04/2006 | CN1277840C Growth hormone releasing compound for treating tumor and inhibitor thereof |
| 10/04/2006 | CN1277824C Piperazine derivatives |
| 10/04/2006 | CN1277823C Novel benzothiazine and benzothiadiazine compounds, its preparation process and pharmaceutical composition containing said compounds |
| 10/04/2006 | CN1277822C Quinazoline derivatives, pharmaceutical composition containing the compound, their utilization and preparation method thereof |
| 10/04/2006 | CN1277820C Phthalimido derivatives as inhibitors of monoamine oxidase B |
| 10/04/2006 | CN1277565C Nutritious drugs for improving children's intelligence |
| 10/04/2006 | CN1277553C Ready Chinese medicine for treating kinetic fatigue and chronic fatigue syndrome |
| 10/04/2006 | CN1277535C Ibuprofen active agent preparation |
| 10/03/2006 | US7115777 For therapy of hypertension, congestive heart failure, cardiac hypertrophy, cardiac fibrosis, cardiomyopathy postinfarction, complications resulting from diabetes, such as nephropathy, vasculopathy and neuropathy, diseases of the coronary vessels, restenosis following angioplasty |
| 10/03/2006 | US7115754 Pyrrolidine derivatives as oxytocin antagonists |
| 10/03/2006 | US7115752 Substituted cyclic compounds |
| 10/03/2006 | US7115739 Triazole compounds useful as protein kinase inhibitors |
| 10/03/2006 | US7115651 Macrocycles and uses thereof |
| 10/03/2006 | US7115650 Administering a composition comprising an inhibitor of dipeptidyl peptidase IV; (2S)-N-isoleucylpyrrolidine-2-carbonitrile; (2S)-N-((2'S)-2'-amino-3',3'-dimethylbutanoyl)pyrrolidine-2-carbonitrile |
| 10/03/2006 | US7115648 use for treating type 2 diabetes, insulin resistance, syndrome X, hyperinsulinaemia, hyperglucagonaemia, cardiac ischaemia and obesity |
| 10/03/2006 | US7115639 useful in the treatment and/or prevention of preterm labor, premature birth and dysmenorrhea; in particular, the present invention is related to pyrrolidine derivatives displaying a substantial modulatory, notably an antagonist activity of the oxytocin receptor |
| 10/03/2006 | US7115633 Benzosuberonylpiperdine compounds as analgesics |
| 10/03/2006 | US7115630 Metabotropic glutamate receptor antagonists |
| 10/03/2006 | US7115629 Carbamates derived from arylalkylamines |
| 10/03/2006 | US7115628 obesity, diabetes, male sexual dysfunction, and female sexual dysfunction |
| 10/03/2006 | US7115626 Treatment of cardiovascular and related pathologies |